South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Government Initiatives, Recent Developments - Forecast to 2028

South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Government Initiatives, Recent Developments - Forecast to 2028


South Korea In-Vitro Diagnostics (IVD) market is predicted to reach US$ 3.7 Billion by 2028. South Korea is one of the emerging markets for in vitro diagnostics (IVD). As in other countries, South Korea is facing the challenges of fighting with infectious disease including HBV, TB, HCV, COVID-19 and HIV, as well as various chronic disease and cancer. In-vitro diagnostics (IVDs) play an important role in the detection of infectious and chronic diseases. In vitro diagnosis refers to the diagnosis of diseases or other condition of the human body through the collection, preparation, and testing of human samples with reagents, instruments, and systems.

Backed by the growing geriatric population and the high burden of chronic and infectious diseases, like diabetes, cancer, and COVID-19, the South Korea IVD market is slated to show significant growth, as these chronic disorders can be diagnosed and monitored using In-vitro diagnostics (IVD) products. Moreover, South Korean government is taking number of initiatives to improve the healthcare sector in the country. For instance, The Korean ‘Act on In Vitro Diagnostic Medical Devices’ came into effect on May 1, 2020, presenting an independent legal foundation to reinforce the IVD industry by promoting advanced technology to be applied promptly. Further, owing to the vast opportunities in this region, key players are coming up with market development strategies to leverage it.

Recent Developments
  • In June 2023, Seegene Inc. obtained the European Union’s In Vitro Diagnostic Medical Device Regulation (IVDR) certification for 30 diagnostic assays.
  • In January 2023, SD Biosensor and SJL Partners completed transaction to acquire Meridian Bioscience.
  • In December 2022, bioMérieux announced the CE-marking of VIDAS KUBE, the next generation automated immunoassay system for the VIDAS range.
  • In July 2022, DiaCarta Inc. received CE-IVD Mark for its newly developed QuantiVirus SARS-CoV-2 & Flu A/B test.
By Technology South Korea IVD Market – Key Takeaway
  • On technology basis, Immunoassay and Clinical Chemistry are the leading segment of the South Korea IVD market. In 2022, they contributed over 60 percent to the total South Korea IVD market.
  • Molecular Diagnostics was responsible for 3rd highest share of the South Korea IVD market.
  • Hematology and Self-Monitoring of Blood Glucose (SMBG) segments are competing closely to grab maximum market share of the pie.
  • Point of Care Testing (POCT) segment held least share of the South Korea IVD market.
By Application South Korea IVD Market – Key Takeaway
  • Based on application, Infectious diseases and Diabetes are the leading segment of the South Korea IVD market. Together they contributed over 50 percent to the total South Korea IVD market.
  • Oncology application segment held 3rd highest share of the South Korea IVD market in 2022, followed by cardiovascular diseases.
  • Autoimmune Diseases was responsible for single digit share of the South Korea IVD market in 2022, while Nephrology held least share of the South Korea IVD market.
By Product South Korea IVD Market – Key Takeaway
  • Reagents held largest share of the South Korea IVD market in 2022 and is expected to remain dominant over the forecast period.
  • The instruments segment was responsible for nearly a quarter of the South Korea IVD market in 2022.
  • The software and services held least share of the South Korea IVD market.
By End User South Korea IVD Market – Key Takeaway
  • Hospitals and Clinics was responsible for lion’s share of the South Korea IVD market in 2022.
  • Diagnostic Laboratories contributed nearly one third to the overall South Korea IVD market in 2022.
South Korea IVD Market - Company Analysis
  • In 2022, Roche diagnostics division generated revenues worth US$ 19,708 Million.
  • In the diagnostics business, Abbott will focus on driving sales growth from its Alinity suite of diagnostics instruments and its portfolio of rapid diagnostic testing system.
  • Seegene Inc. sales revenue increased by more than ninefold year-on-year in 2020.
  • In May 2023, Siemens Healthineers announced the launch of next-gen hematology analyzers: Atellica HEMA 570 Analyzer and the Atellica HEMA 580 Analyzer.
  • SD BioSensor’s sales revenue rose 23-fold year-on-year in 2020.
iGATE RESEARCH report titled “South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Government Initiatives, Recent Developments - Forecast to 2028” provides a comprehensive analysis of the South Korea In-Vitro Diagnostics (IVD) Market.

This 274 Pages report with 71 Figures and 9 Tables has been analyzed from 10 View Points:

1) South Korea IVD Market and Forecast (2018 - 2028)
2) South Korea IVD Market Share and Forecast (2018 - 2028)
3) South Korea IVD Market & Forecast - By Technology (2018 - 2028)
4) South Korea IVD Market & Forecast - By Application (2018 - 2028)
5) South Korea IVD Market & Forecast - By Product (2018 - 2028)
6) South Korea IVD Market & Forecast - By End User (2018 - 2028)
7) South Korea IVD Market - Key Players Analysis (2014 - 2028)
8) In-Vitro Diagnostics (IVD) Market - Major Deals
9) In-Vitro Diagnostics (IVD) Market - Recent Developments
10) South Korea IVD Market - Industry Drivers & Challenges

By Technology - South Korea IVD Market and Forecast

1. Immunoassay
2. Clinical Chemistry
3. Hematology
4. Coagulation/Hemostasis
5. Microbiology
6. Molecular Diagnostic
7. Self-Monitoring of Blood Glucose (SMBG)
8. Point of Care Testing (POCT)
9. Others

By Application - South Korea IVD Market and Forecast

1. Infectious Diseases
2. Cardiovascular Diseases
3. Diabetes
4. Oncology
5. Nephrology
6. Autoimmune Diseases
7. Others

By Product - South Korea IVD Market and Forecast
  • Reagents
  • Instruments
  • Software and Services
By End User - South Korea IVD Market and Forecast
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Other End Users
South Korea IVD Market - Key Players Analysis

1. Roche
2. Abbott
3. Sysmex Corporation
4. Danaher Corporation
5. Thermo Fischer Scientific Inc.
6. Siemens Healthineers
7. Biomerieux SA
8. Bio-Rad Laboratories, Inc
9. Becton Dickinson and Company
10. Nihon Kohden Corporation
11. Seegene Inc.
12. SD Biosensor Inc.
13. Sugentech Inc.

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies:


Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies:

Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.


1. Executive Summary
2. South Korea In-Vitro Diagnostics (IVD) Market and Forecast (2018 - 2028)
3. South Korea In-Vitro Diagnostics (IVD) Market Share and Forecast (2018 - 2028)
3.1 By Technology - South Korea In-Vitro Diagnostics (IVD) Market Share and Forecast
3.2 By Application - South Korea In-Vitro Diagnostics (IVD) Market Share and Forecast
3.3 By Product - South Korea In-Vitro Diagnostics (IVD) Market Share and Forecast
3.4 By End User - South Korea In-Vitro Diagnostics (IVD) Market Share and Forecast
4. By Technology - South Korea In-Vitro Diagnostics (IVD) Market and Forecast (2018 - 2028)
4.1 South Korea - Immunoassay Market and Forecast
4.2 South Korea - Clinical Chemistry Market and Forecast
4.3 South Korea - Hematology Market and Forecast
4.4 South Korea - Coagulation/Hemostasis Market and Forecast
4.5 South Korea - Microbiology Market and Forecast
4.6 South Korea - Molecular Diagnostics Market and Forecast
4.7 South Korea - Self Monitoring of Blood Glucose (SMBG) Market and Forecast
4.8 South Korea - Point of Care Testing (POCT) Market and Forecast
4.9 South Korea - Others Market and Forecast
5. By Application - South Korea In-Vitro Diagnostics (IVD) Market and Forecast (2018 - 2028)
5.1 South Korea - Infectious Diseases Market and Forecast
5.2 South Korea - Cardiovascular Diseases Market and Forecast
5.3 South Korea - Diabetes Market and Forecast
5.4 South Korea - Oncology Market and Forecast
5.5 South Korea - Nephrology Market and Forecast
5.6 South Korea - Autoimmune Diseases Market and Forecast
5.7 South Korea - Others Market and Forecast
6. By Product - South Korea In-Vitro Diagnostics (IVD) Market and Forecast (2018 - 2028)
6.1 South Korea In-Vitro Diagnostics - Reagents Market and Forecast
6.2 South Korea In-Vitro Diagnostics - Instruments Market and Forecast
6.3 South Korea In-Vitro Diagnostics - Software and Services Market and Forecast
7. By End User - South Korea In-Vitro Diagnostics (IVD) Market and Forecast (2018 - 2028)
7.1 South Korea In-Vitro Diagnostics - Hospitals and Clinics Market and Forecast
7.2 South Korea In-Vitro Diagnostics - Diagnostic Laboratories Market and Forecast
7.3 South Korea In-Vitro Diagnostics - Other End Users Market and Forecast
8. South Korea IVD Market - Key Players Analysis (2014 - 2028)
8.1 Roche
8.1.1 Company Overview
8.1.2 Recent Developments
8.1.3 Diagnostics Revenue and Forecast
8.2 Abbott
8.2.1 Company Overview
8.2.2 Recent Developments
8.2.3 Diagnostics Revenue and Forecast
8.3 Sysmex Corporation
8.3.1 Company Overview
8.3.2 Recent Developments
8.3.3 Diagnostics Revenue and Forecast
8.4 Danaher Corporation
8.4.1 Company Overview
8.4.2 Recent Developments
8.4.3 Diagnostics Revenue and Forecast
8.5 Thermo Fischer Scientific
8.5.1 Company Overview
8.5.2 Recent Developments
8.5.3 Diagnostics Revenue and Forecast
8.6 Siemens Healthineers
8.6.1 Company Overview
8.6.2 Recent Developments
8.6.3 Diagnostics Revenue and Forecast
8.7 Biomerieux SA
8.7.1 Company Overview
8.7.2 Recent Developments
8.7.3 Diagnostics Revenue and Forecast
8.8 Bio-Rad Laboratories, Inc.
8.8.1 Business Overview
8.8.2 Recent Developments
8.8.3 Diagnostics Revenue and Forecast
8.9 Becton Dickinson and Company
8.9.1 Business Overview
8.9.2 Recent Initiatives/ Strategy/ Developments
8.9.3 Diagnostics Revenue and Forecast
8.10 Nihon Kohden Corporation
8.10.1 Business Overview
8.10.2 Recent Developments
8.10.3 Global Revenue and Forecast
8.11 Seegene Inc.
8.11.1 Business Overview
8.11.2 Recent Developments
8.11.3 Global Revenue and Forecast
8.12 SD Biosensor Inc.
8.12.1 Business Overview
8.12.2 Recent Developments
8.12.3 Global Revenue
8.13 Sugentech Inc.
8.13.1 Business Overview
8.13.2 Recent Developments
8.13.3 Global Revenue and Forecast
9. In-Vitro Diagnostics (IVD) Market - Major Deals
9.1 2023
9.2 2022
9.3 2021
9.4 2020
9.5 2019
10. In-Vitro Diagnostics (IVD) Market - Recent Developments
11. South Korea In-Vitro Diagnostics (IVD) Market - Driving Factors
11.1 Government Initiatives Drives In-Vitro Diagnostics (IVD) Market
11.1.1 South Korea - Act on In Vitro Diagnostic Medical Devices
11.1.2 South Korea - Classification of In Vitro Diagnostic Medical Devices
11.2 Rising Incidence of Various Infectious and Chronic Diseases
11.3 Expanding Elderly Population Segment
11.4 Technology Advancement Spurring the IVD Market
12. South Korea In-Vitro Diagnostics (IVD) Market - Challenges
12.1 Operational Barriers Faced in Conducting Diagnostic Tests
12.2 Regulatory Challenges
List of Figures:
Figure 2-1: South Korea In-Vitro Diagnostics (IVD) Market (Million US$), 2018 - 2022
Figure 2-2: Forecast for South Korea In-Vitro Diagnostics (IVD) Market (Million US$), 2023 - 2028
Figure 4-1: South Korea - Immunoassay Market (Million US$), 2018 - 2022
Figure 4-2: South Korea - Forecast for Immunoassay Market (Million US$), 2023 - 2028
Figure 4-3: South Korea - Clinical Chemistry Market (Million US$), 2018 - 2022
Figure 4-4: South Korea - Forecast for Clinical Chemistry Market (Million US$), 2023 - 2028
Figure 4-5: South Korea - Hematology Market (Million US$), 2018 - 2022
Figure 4-6: South Korea - Forecast for Hematology Market (Million US$), 2023 - 2028
Figure 4-7: South Korea - Coagulation/Hemostasis Market (Million US$), 2018 - 2022
Figure 4-8: South Korea - Forecast for Coagulation/Hemostasis Market (Million US$), 2023 - 2028
Figure 4-9: South Korea - Microbiology Market (Million US$), 2018 - 2022
Figure 4-10: South Korea - Forecast for Microbiology Market (Million US$), 2023 - 2028
Figure 4-11: South Korea - Molecular Diagnostics Market (Million US$), 2018 - 2022
Figure 4-12: South Korea - Forecast for Molecular Diagnostics Market (Million US$), 2023 - 2028
Figure 4-13: South Korea - Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2018 - 2022
Figure 4-14: South Korea - Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2023 - 2028
Figure 4-15: South Korea - Point of Care Testing (POCT) Market (Million US$), 2018 - 2022
Figure 4-16: South Korea - Forecast for Point of Care Testing (POCT) Market (Million US$), 2023 - 2028
Figure 4-17: South Korea - Others Market (Million US$), 2018 - 2022
Figure 4-18: South Korea - Forecast for Others Market (Million US$), 2023 - 2028
Figure 5-1: South Korea - Infectious Diseases Market (Million US$), 2018 - 2022
Figure 5-2: South Korea - Forecast for Infectious Diseases Market (Million US$), 2023 - 2028
Figure 5-3: South Korea - Cardiovascular Diseases Market (Million US$), 2018 - 2022
Figure 5-4: South Korea - Forecast for Cardiovascular Diseases Market (Million US$), 2023 - 2028
Figure 5-5: South Korea - Diabetes Market (Million US$), 2018 - 2022
Figure 5-6: South Korea - Forecast for Diabetes Market (Million US$), 2023 - 2028
Figure 5-7: South Korea - Oncology Market (Million US$), 2018 - 2022
Figure 5-8: South Korea - Forecast for Oncology Market (Million US$), 2023 - 2028
Figure 5-9: South Korea - Nephrology Market (Million US$), 2018 - 2022
Figure 5-10: South Korea - Forecast for Nephrology Market (Million US$), 2023 - 2028
Figure 5-11: South Korea - Autoimmune Diseases Market (Million US$), 2018 - 2022
Figure 5-12: South Korea - Forecast for Autoimmune Diseases Market (Million US$), 2023 - 2028
Figure 5-13: South Korea - Others Market (Million US$), 2018 - 2022
Figure 5-14: South Korea - Forecast for Others Market (Million US$), 2023 - 2028
Figure 6-1: South Korea IVD - Reagents Market (Million US$), 2018 - 2022
Figure 6-2: South Korea IVD - Forecast for Reagents Market (Million US$), 2023 - 2028
Figure 6-3: South Korea IVD - Instruments Market (Million US$), 2018 - 2022
Figure 6-4: South Korea IVD - Forecast for Instruments Market (Million US$), 2023 - 2028
Figure 6-5: South Korea IVD - Software and Services Market (Million US$), 2018 - 2022
Figure 6-6: South Korea IVD - Forecast for Software and Services Market (Million US$), 2023 - 2028
Figure 7-1: South Korea IVD - Hospitals and Clinics Market (Million US$), 2018 - 2022
Figure 7-2: South Korea IVD - Forecast for Hospitals and Clinics Market (Million US$), 2023 - 2028
Figure 7-3: South Korea IVD - Diagnostic Laboratories Market (Million US$), 2018 - 2022
Figure 7-4: South Korea IVD - Forecast for Diagnostic Laboratories Market (Million US$), 2023 - 2028
Figure 7-5: South Korea IVD - Other End Users Market (Million US$), 2018 - 2022
Figure 7-6: South Korea IVD - Forecast for Other End Users Market (Million US$), 2023 - 2028
Figure 8-1: Roche Diagnostics - Global Diagnostics Revenue (Million US$), 2013 - 2022
Figure 8-2: Roche Diagnostics - Forecast for Global Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-3: Abbott Laboratories - Global Diagnostics Revenue (Million US$), 2013 - 2022
Figure 8-4: Abbott Laboratories - Forecast for Global Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-5: Sysmex Corporation - Global Diagnostics Revenue (Million US$), 2014 - 2022
Figure 8-6: Sysmex Corporation - Forecast for Global Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-7: Danaher Corporation - Global Diagnostics Revenue (Million US$), 2014 - 2022
Figure 8-8: Danaher Corporation - Forecast for Global Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-9: Thermo Fisher Scientific - Global Specialty Diagnostics Revenue (Million US$), 2013 - 2022
Figure 8-10: Thermo Fisher Scientific - Forecast for Global Specialty Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-11: Siemens Healthineers - Global Diagnostics Revenue (Million US$), 2013 - 2022
Figure 8-12: Siemens Healthineers - Forecast for Global Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-13: bioMérieux - Global Diagnostics Revenue (Million US$), 2015 - 2022
Figure 8-14: bioMérieux - Forecast for Global Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-15: Bio-Rad Laboratories, Inc. - Global Diagnostics Revenue (Million US$), 2014 - 2022
Figure 8-16: Bio-Rad Laboratories, Inc. - Forecast for Global Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-17: Becton Dickinson and Company - Global Diagnostics Revenue (Million US$), 2014 - 2022
Figure 8-18: Becton Dickinson and Company - Forecast for Global Diagnostics Revenue (Million US$), 2023 - 2028
Figure 8-19: Nihon Kohden Corporation - Global Revenue (Million US$), 2015 - 2022
Figure 8-20: Nihon Kohden Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 8-21: Seegene Inc. - Global Revenue (Million US$), 2015 - 2022
Figure 8-22: Seegene Inc. - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 8-23: SD Biosensor Inc. - Global Revenue (Million US$), 2019 - 2022
Figure 8-24: Sugentech Inc. - Global Revenue (Million US$), 2015 - 2022
Figure 8-25: Sugentech Inc. - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables:
Table 3-1: By Technology - South Korea In-Vitro Diagnostics (IVD) Market Share (Percent), 2018 - 2022
Table 3-2: By Technology - Forecast for South Korea In-Vitro Diagnostics (IVD) Market Share (Percent), 2023 - 2028
Table 3-3: By Application - South Korea In-Vitro Diagnostics (IVD) Market Share (Percent), 2018 - 2022
Table 3-4: By Application - Forecast for South Korea In-Vitro Diagnostics (IVD) Market Share (Percent), 2023 - 2028
Table 3-5: By Product - South Korea In-Vitro Diagnostics (IVD) Market Share (Percent), 2018 - 2022
Table 3-6: By Product - Forecast for South Korea In-Vitro Diagnostics (IVD) Market Share (Percent), 2023 - 2028
Table 3-7: By End User - South Korea In-Vitro Diagnostics (IVD) Market Share (Percent), 2018 - 2022
Table 3-8: By End User - Forecast for South Korea In-Vitro Diagnostics (IVD) Market Share (Percent), 2023 - 2028
Table 11-1: South Korea - Criteria for the Classification of In Vitro Diagnostic Medical Devices

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings